Evidence map›Paper›PMID 16408226›Full record

ArticleEuropean journal of clinical pharmacology2006

Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.

Johanna Jyrkkä, Leena Vartiainen, Sirpa Hartikainen, Raimo Sulkava, Hannes Enlund

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Polypharmacy in Polish Older Adult Population-A Cross-Sectional Study: Results of the PolSenior Project.International journal of environmental research and public health · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Polypharmacy in the terminal stage of cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Social Pharmacy and Clinical Pharmacy-Joining Forces.Pharmacy (Basel, Switzerland) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Johanna JyrkkäDepartment of Social Pharmacy, University of Kuopio, Box 1627, FIN, 70211, Kuopio, Finland. Johanna.Jyrkka@uku.fi
Leena Vartiainen
Sirpa Hartikainen
Raimo Sulkava
Hannes Enlund
University of Eastern Finland · FINiuvanniemi Hospital · FIRehabilitation Foundation · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to describe the changes in medicine use, polypharmacy and excessive polypharmacy between 1998 and 2003 among a cohort of elderly Finns.

methodsFor this prospective follow-up study, a random sample of 700 participants aged >or=75 years was drawn from the City of Kuopio, Finland. Of them, 601 participated in the study at baseline in 1998. The changes in medicine use among the survivors (n=339), who were re-examined in 2003, were recorded and are described here. Statistical significance of changes in medicine use was evaluated by Student's paired-samples and independent-samples t-test and Fisher's exact test.

resultsFrom 1998 to 2003, the mean number of medicines in use per individual increased from 6.3 to 7.5 (p<0.001). The prevalence of polypharmacy (>5 medicines in use) increased from 54% to 67% and excessive polypharmacy (>or=10 medicines in use) from 19% to 28%. The increase was due to increased use of regularly taken medicines, whereas the use of medicines taken as needed decreased during the follow-up in both sexes. At the time of follow-up survey, persons in institutional care used significantly more medicines (10.9) than community-dwelling elderly persons (7.0) (p<0.001). Central nervous system medicines and cardiovascular medicines were the most commonly used medicines in both years.

conclusionThe number of medicines and the prevalence of polypharmacy and excessive polypharmacy increases with advancing age. In order to avoid possible harmful effects and to optimize medication it is necessary to assess the medication regimen at regular intervals.

Indexed as

PolypharmacyAgedAged, 80 and overAge FactorsCardiovascular AgentsCentral Nervous System AgentsData CollectionDrug PrescriptionsDrug UtilizationFemaleFinlandFollow-Up StudiesHumansMaleProspective StudiesCardiovascular AgentsCentral Nervous System Agents

Identifiers

PMID16408226
OpenAlexW1971720400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.